Clinical Trials Browser

Terminated × Risedronic Acid × Clear all

NCT00216060 2016-05-26

Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy

Phase 3 Terminated

63 enrolled 19 charts

Prostatic Neoplasms

NCT00145704 2013-04-08

Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density

Phase NA Terminated

6 enrolled 3 charts

Bone Diseases, Metabolic, Dwarfism, Pituitary